Canadian pharmacy and therapeutics news: recalls, shortages, guideline updates and developments in practice.
Two clinical handouts give different Wegovy click counts. A Canadian educational review explains the discrepancy, pen formats and manufacturer instructions.
Nov 4, 2026 · 5 min read Read briefing
Ozempic pens with the same total contents can have different labelled dose settings. This educational review examines a published click chart and its limits.
Nov 4, 2026 · 5 min read Read briefing
What published Zepbound click charts calculate, why they are off-label, and how Canadian KwikPen dose settings and discard rules differ from the arithmetic.
Nov 4, 2026 · 5 min read Read briefing
Health Canada has issued a national Type I recall for one lot of Marcan cyclophosphamide 1,000 mg/vial after particulate matter was found. The notice is directed to healthcare establishments; pharmacy teams should confirm whether the lot is in stock and follow the manufacturer’s recall instructions.
Nov 3, 2026 · 3 min read Read briefing
Health Canada’s new guidance explains how existing drug-trial rules apply when visits, consent, data collection or investigational-product delivery move beyond traditional research sites. The update gives community health professionals a clearer view of their possible role—and the safeguards that remain.
Nov 3, 2026 · 4 min read Read briefing
Eli Lilly says its investigational weekly retatrutide reduced A1c and body weight more than semaglutide 2 mg in an 80-week, open-label Phase 3 trial. Full results are not yet peer-reviewed, and retatrutide is not approved for routine use.
Nov 3, 2026 · 4 min read Read briefing
Health Canada added estrogen transdermal patches to its Tier 3 shortage list on Oct. 28. The designation signals high potential system impact, but does not identify which products are unavailable or confirm a nationwide stockout.
Oct 31, 2026 · 4 min read Read briefing
A coalition of health organizations renewed its call for Canada to finalize a 2021 draft restricting most vaping flavours. The proposal remains distinct from rules in force today.
Oct 31, 2026 · 3 min read Read briefing